
While advances in technology have made multigene testing, or ‘panel testing,’ for genetic mutations that increase the risk of breast or other cancers an option, authors of a review say larger studies are needed in order to provide reliable risk estimates for counseling these patients.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/MxPVzyINZG0/150527180956.htm